CSL Ltd Cash Flow Statement Analysis
ASX:CSL
Health Care
•
Biotechnology
Cash Flow Statement
Comprehensive analysis of CSL Ltd's cash flow activities
| Items | 2024 | 2025 | |
|---|---|---|---|
| Operating Activities | |||
| Net Income | - | - | |
| Cash from Operating Activities | 2.8B | 3.6B | |
| Investing Activities | |||
| Investments in PPE | (566M) | (636M) | |
| Cash from Investing Activities | (1.3B) | (850M) | |
| Financing Activities | |||
| Debt Repayments | 41M | (735M) | |
| Share Repurchases | - | - | |
| Dividends Paid | (1.3B) | (1.4B) | |
| Cash from Financing Activities | (1.3B) | (2.2B) | |
| Cash Position | |||
| Cash at Beginning of Period | 1.5B | 1.6B | |
| Cash at End of Period | 1.6B | 2.2B | |
| Free Cash Flow | |||
| Free Cash Flow (Reported) | 1.5B | 2.5B | |
| Free Cash Flow (Calculated) | 2.2B | 2.9B |
Note: Fiscal year ends in June. All amounts are in the original currency (AUD). Values displayed in millions (M) or billions (B) where applicable. Negative amounts shown in red parentheses.